Literature DB >> 10029169

Cord blood is better than bone marrow for generating megakaryocytic progenitor cells.

H Tao1, L Gaudry, A Rice, B Chong.   

Abstract

Thrombocytopenia remains an important problem for patients post high-dose chemotherapy and hematopoietic stem cell transplantation. The study of megakaryocytes, the direct precursors of platelets, has been hampered by their relatively low frequency in hematopoietic tissues. In an attempt to obtain a large number of functional megakaryocytic cells, we established a serum-free culture system to grow megakaryocytic progenitor cells derived from normal human bone marrow (BM) and cord blood (CB). Highly purified (purity >95%) CD34+ cells were obtained using magnetic cell sorting (MACS) followed by fluorescence activated cell sorting (FACS). The cells were cultured in a serum-free culture system for 3 weeks in the presence of a single dose of MGDF (50 ng/mL). On days 0, 5, 8, 12, 14, 18, and 21 of culture, the cellularity and morphology were examined. Megakaryocytic cells were monitored by detecting the expression of GPIIIa (CD61), GPIIb/IIIa (CD41) and GPIb (CD42b), and the distribution of megakaryocyte (MK) ploidy was analyzed by two-color flow cytometry. MGDF alone induced maximal nucleated cell expansion at day 14, resulting in a 38.20+/-10.47-fold increase in cell number for CB and a 5.08+/-1.30-fold increase in cell number for BM. On day 14 of the culture, the percentage of CD41-/CD14- cells derived from CB reached 73.54%+/-6.01% giving an absolute number of CD41+/CD14- cells of 27.25+/-2.23 x 10(4)/mL (27,250-fold increase), whilst the percentage of CD41+/CD14- cells derived from BM was only 29.21%+/-5.63% with an absolute number of 1.36+/-0.26 x 10(4)/mL (680-fold increase). Increased expression of GPIIIa occurred the earliest in culture, followed by GPIIb/IIIa, and then GPIb. The majority (81.6%-92.6%) of megakaryocytes (CD41+ cells) on day 14 of culture were 2N, although we did detect some 4N, 8N and greater ploidy cells. In conclusion, CD34+ cells stimulated by MGDF alone generated highly enriched MK progenitor cells at day 14 of serum-free culture. CB stem and progenitor cells have a greater proliferative response to MGDF alone than those derived from BM and may, therefore, prove to be a better source of cells for MK expansion.

Entities:  

Mesh:

Year:  1999        PMID: 10029169     DOI: 10.1016/s0301-472x(98)00050-2

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  13 in total

1.  What is the future for cord blood stem cells?

Authors:  E A de Wynter
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

2.  Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.

Authors:  Muna Iraqi; Jose Perdomo; Feng Yan; Philip Y-I Choi; Beng H Chong
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

3.  SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells.

Authors:  Miguel G Toscano; Oscar Navarro-Montero; Veronica Ayllon; Veronica Ramos-Mejia; Xiomara Guerrero-Carreno; Clara Bueno; Tamara Romero; Mar Lamolda; Marien Cobo; Francisco Martin; Pablo Menendez; Pedro J Real
Journal:  Mol Ther       Date:  2014-10-08       Impact factor: 11.454

Review 4.  Challenges and promises for the development of donor-independent platelet transfusions.

Authors:  Michele P Lambert; Spencer K Sullivan; Rudy Fuentes; Deborah L French; Mortimer Poncz
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

Review 5.  In vitro megakaryocyte production and platelet biogenesis: state of the art.

Authors:  Jo-Anna Reems; Nicolas Pineault; Sijie Sun
Journal:  Transfus Med Rev       Date:  2010-01

6.  Differentiated Cells Derived from Hematopoietic Stem Cells and Their Applications in Translational Medicine.

Authors:  Sophia S Fernandes; Lalita S Limaye; Vaijayanti P Kale
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Platelet generation in vivo and in vitro.

Authors:  Biao Wang; Jiansheng Zheng
Journal:  Springerplus       Date:  2016-06-21

Review 8.  On the Quest for In Vitro Platelet Production by Re-Tailoring the Concepts of Megakaryocyte Differentiation.

Authors:  Patricia Martínez-Botía; Andrea Acebes-Huerta; Jerard Seghatchian; Laura Gutiérrez
Journal:  Medicina (Kaunas)       Date:  2020-12-03       Impact factor: 2.430

9.  In vitro megakaryocyte culture from human bone marrow aspirates as a research and diagnostic tool.

Authors:  Kirill R Butov; Elena Y Osipova; Nikita B Mikhalkin; Natalia M Trubina; Mikhail A Panteleev; Kellie R Machlus
Journal:  Platelets       Date:  2020-09-16       Impact factor: 4.236

Review 10.  Von Willebrand Disease: From In Vivo to In Vitro Disease Models.

Authors:  Suzan de Boer; Jeroen Eikenboom
Journal:  Hemasphere       Date:  2019-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.